Transitional Management: The Use of Oral Contraceptives in Perimenopause
ByAndrew M. Kaunitz, MD,Ronald T. Burkman, MD,Sandra Ann Carson, MD,Paula J. Hillard, MD,J. Kell Williams, MD,Andrew M. Kaunitz, MD,Ronald T. Burkman, MD,Andrew M. Kaunitz, MD,John A. Collins, MD,Maida B. Taylor, MD, MPh,Susan J. Wysocki, RNC, NP,Ronald T. Burkman, MD,Andrew M. Kaunitz, MD,John A. Collins, MD,Maida B. Taylor, MD, MPh,Susan J. Wysocki, RNC, NP,Ronald T. Burkman, MD,Andrew M. Kaunitz, MD,John A. Collins, MD,Maida B. Taylor, MD, MPh,Susan J. Wysocki, RNC, NP
A number of perimenopausal women and their health care providers choose to either decline or prematurely discontinue use of oral contraceptives (OCs), despite the availability of formulations that can prevent pregnancy and address perimenopausal symptoms. This lack of use is due to several factors.
